Literature DB >> 16452126

MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene.

Clelia Tiziana Storlazzi1, Thoas Fioretos, Cecilia Surace, Angelo Lonoce, Angela Mastrorilli, Bodil Strömbeck, Pietro D'Addabbo, Francesco Iacovelli, Crescenzio Minervini, Anna Aventin, Nicole Dastugue, Christa Fonatsch, Anne Hagemeijer, Martine Jotterand, Dominique Mühlematter, Marina Lafage-Pochitaloff, Florence Nguyen-Khac, Claudia Schoch, Marilyn L Slovak, Arabella Smith, Francesc Solè, Nadine Van Roy, Bertil Johansson, Mariano Rocchi.   

Abstract

Double minutes (dmin)-circular, extra-chromosomal amplifications of specific acentric DNA fragments-are relatively frequent in malignant disorders, particularly in solid tumors. In acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), dmin are observed in approximately 1% of the cases. Most of them consist of an amplified segment from chromosome band 8q24, always including the MYC gene. Besides this information, little is known about their internal structure. We have characterized in detail the genomic organization of 32 AML and two MDS cases with MYC-containing dmin. The minimally amplified region was shown to be 4.26 Mb in size, harboring five known genes, with the proximal and the distal amplicon breakpoints clustering in two regions of approximately 500 and 600 kb, respectively. Interestingly, in 23 (68%) of the studied cases, the amplified region was deleted in one of the chromosome 8 homologs at 8q24, suggesting excision of a DNA segment from the original chromosomal location according to the 'episome model'. In one case, sequencing of both the dmin and del(8q) junctions was achieved and provided definitive evidence in favor of the episome model for the formation of dmin. Expression status of the TRIB1 and MYC genes, encompassed by the minimally amplified region, was assessed by northern blot analysis. The TRIB1 gene was found over-expressed in only a subset of the AML/MDS cases, whereas MYC, contrary to expectations, was always silent. The present study, therefore, strongly suggests that MYC is not the target gene of the 8q24 amplifications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16452126     DOI: 10.1093/hmg/ddl010

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  44 in total

1.  Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences.

Authors:  Leonora Balaj; Ryan Lessard; Lixin Dai; Yoon-Jae Cho; Scott L Pomeroy; Xandra O Breakefield; Johan Skog
Journal:  Nat Commun       Date:  2011-02-01       Impact factor: 14.919

Review 2.  Cytogenetic, molecular genetic, and clinical characteristics of acute myeloid leukemia with a complex karyotype.

Authors:  Krzysztof Mrózek
Journal:  Semin Oncol       Date:  2008-08       Impact factor: 4.929

3.  The Hidden Genomic and Transcriptomic Plasticity of Giant Marker Chromosomes in Cancer.

Authors:  Gemma Macchia; Marco Severgnini; Stefania Purgato; Doron Tolomeo; Hilen Casciaro; Ingrid Cifola; Alberto L'Abbate; Anna Loverro; Orazio Palumbo; Massimo Carella; Laurence Bianchini; Giovanni Perini; Gianluca De Bellis; Fredrik Mertens; Mariano Rocchi; Clelia Tiziana Storlazzi
Journal:  Genetics       Date:  2017-12-26       Impact factor: 4.562

4.  Impediment of Replication Forks by Long Non-coding RNA Provokes Chromosomal Rearrangements by Error-Prone Restart.

Authors:  Takaaki Watanabe; Michael Marotta; Ryusuke Suzuki; Scott J Diede; Stephen J Tapscott; Atsushi Niida; Xiongfong Chen; Lila Mouakkad; Anna Kondratova; Armando E Giuliano; Sandra Orsulic; Hisashi Tanaka
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

Review 5.  Brain tumor microvesicles: insights into intercellular communication in the nervous system.

Authors:  Kristan E van der Vos; Leonora Balaj; Johan Skog; Xandra O Breakefield
Journal:  Cell Mol Neurobiol       Date:  2011-05-08       Impact factor: 5.046

6.  Frequency of double minute chromosomes and combined cytogenetic abnormalities and their characteristics.

Authors:  Yihui Fan; Renfang Mao; Hongpei Lv; Jie Xu; Lei Yan; Yanhong Liu; Meng Shi; Guohua Ji; Yang Yu; Jing Bai; Yan Jin; Songbin Fu
Journal:  J Appl Genet       Date:  2010-11-11       Impact factor: 3.240

Review 7.  Extrachromosomal oncogene amplification in tumour pathogenesis and evolution.

Authors:  Roel G W Verhaak; Vineet Bafna; Paul S Mischel
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

8.  Myc roles in hematopoiesis and leukemia.

Authors:  M Dolores Delgado; Javier León
Journal:  Genes Cancer       Date:  2010-06

9.  Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia.

Authors:  Letetia Jones; Guangwei Wei; Sabina Sevcikova; Vernon Phan; Sachi Jain; Angell Shieh; Jasmine C Y Wong; Min Li; Joshua Dubansky; Mei Lin Maunakea; Rachel Ochoa; George Zhu; Thelma R Tennant; Kevin M Shannon; Scott W Lowe; Michelle M Le Beau; Scott C Kogan
Journal:  J Exp Med       Date:  2010-11-08       Impact factor: 14.307

Review 10.  MYC oncogene in myeloid neoplasias.

Authors:  M Dolores Delgado; Marta Albajar; M Teresa Gomez-Casares; Ana Batlle; Javier León
Journal:  Clin Transl Oncol       Date:  2012-08-22       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.